It is time to optimise the management of latent tuberculosis infection in children

Eur Respir J. 2021 Apr 22;57(4):2004438. doi: 10.1183/13993003.04438-2020. Print 2021 Apr.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Child
  • Humans
  • Latent Tuberculosis* / diagnosis
  • Latent Tuberculosis* / drug therapy